EA200870603A1 - Лечение опухолей у педиатрических пациентов антагонистами рецептора эпидермального фактора роста - Google Patents
Лечение опухолей у педиатрических пациентов антагонистами рецептора эпидермального фактора ростаInfo
- Publication number
- EA200870603A1 EA200870603A1 EA200870603A EA200870603A EA200870603A1 EA 200870603 A1 EA200870603 A1 EA 200870603A1 EA 200870603 A EA200870603 A EA 200870603A EA 200870603 A EA200870603 A EA 200870603A EA 200870603 A1 EA200870603 A1 EA 200870603A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- tumors
- antagonists
- treatment
- epidermal growth
- pediatric patients
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 239000005557 antagonist Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 229940122558 EGFR antagonist Drugs 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83348706P | 2006-07-27 | 2006-07-27 | |
| PCT/US2007/074448 WO2008014386A2 (fr) | 2006-07-27 | 2007-07-26 | Traitement de tumeurs chez des patients pédiatriques avec des antagonistes des récepteurs du facteur de croissance épidermique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200870603A1 true EA200870603A1 (ru) | 2009-06-30 |
Family
ID=38982334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200870603A EA200870603A1 (ru) | 2006-07-27 | 2007-07-26 | Лечение опухолей у педиатрических пациентов антагонистами рецептора эпидермального фактора роста |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP2043688A4 (fr) |
| JP (1) | JP2009544736A (fr) |
| KR (1) | KR20090033841A (fr) |
| CN (1) | CN101484186A (fr) |
| AU (1) | AU2007279261A1 (fr) |
| BR (1) | BRPI0712368A2 (fr) |
| CA (1) | CA2654911A1 (fr) |
| CR (1) | CR10486A (fr) |
| EA (1) | EA200870603A1 (fr) |
| EC (1) | ECSP089011A (fr) |
| MX (1) | MX2008016187A (fr) |
| NO (1) | NO20085182L (fr) |
| TN (1) | TNSN08512A1 (fr) |
| WO (1) | WO2008014386A2 (fr) |
| ZA (1) | ZA200810600B (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020249296A1 (en) * | 2019-03-27 | 2021-11-11 | National Research Council Of Canada | Anti-EGFRvIII antibodies and antigen-binding fragments thereof |
-
2007
- 2007-07-26 JP JP2009522001A patent/JP2009544736A/ja not_active Withdrawn
- 2007-07-26 AU AU2007279261A patent/AU2007279261A1/en not_active Abandoned
- 2007-07-26 BR BRPI0712368-0A patent/BRPI0712368A2/pt not_active Application Discontinuation
- 2007-07-26 KR KR1020087031606A patent/KR20090033841A/ko not_active Withdrawn
- 2007-07-26 EP EP07813400A patent/EP2043688A4/fr not_active Withdrawn
- 2007-07-26 MX MX2008016187A patent/MX2008016187A/es not_active Application Discontinuation
- 2007-07-26 CN CNA2007800249991A patent/CN101484186A/zh active Pending
- 2007-07-26 EA EA200870603A patent/EA200870603A1/ru unknown
- 2007-07-26 CA CA002654911A patent/CA2654911A1/fr not_active Abandoned
- 2007-07-26 WO PCT/US2007/074448 patent/WO2008014386A2/fr not_active Ceased
-
2008
- 2008-12-09 CR CR10486A patent/CR10486A/es not_active Application Discontinuation
- 2008-12-11 TN TNP2008000512A patent/TNSN08512A1/en unknown
- 2008-12-11 NO NO20085182A patent/NO20085182L/no not_active Application Discontinuation
- 2008-12-15 ZA ZA200810600A patent/ZA200810600B/xx unknown
- 2008-12-24 EC EC2008009011A patent/ECSP089011A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TNSN08512A1 (en) | 2010-04-14 |
| CA2654911A1 (fr) | 2008-01-30 |
| JP2009544736A (ja) | 2009-12-17 |
| BRPI0712368A2 (pt) | 2012-06-05 |
| WO2008014386A3 (fr) | 2008-07-03 |
| KR20090033841A (ko) | 2009-04-06 |
| CN101484186A (zh) | 2009-07-15 |
| MX2008016187A (es) | 2009-01-20 |
| CR10486A (es) | 2009-02-23 |
| ECSP089011A (es) | 2009-01-30 |
| EP2043688A2 (fr) | 2009-04-08 |
| NO20085182L (no) | 2009-04-24 |
| ZA200810600B (en) | 2009-11-25 |
| WO2008014386A2 (fr) | 2008-01-31 |
| EP2043688A4 (fr) | 2009-11-11 |
| AU2007279261A1 (en) | 2008-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY183404A (en) | Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors | |
| BRPI0908635B8 (pt) | composto e/ou um sal farmaceuticamente aceitável do mesmo e composição farmacêutica | |
| RU2013148721A (ru) | Комбинации соединений, ингибирующих акт и вемурафениба и способы их применения | |
| EA201100971A1 (ru) | Производные пиримидининдола для лечения злокачественного новообразования | |
| EA201000914A1 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
| CL2008001932A1 (es) | Compuestos derivados de 6-cicloamino-3-(piridin-4-il)imidazo[1,2-b]piridazina, inhibidores de cq1epsilon y/o ck1delta; procedimiento de preparacion; composicion farmaceutica que los comprende; y uso en el tratamiento de desordenes del sueno, trastorno del ritmo circadiano, cancer y enfermedad de alzheimer. | |
| EA200970953A1 (ru) | СПЕЦИФИЧНЫЕ ИНГИБИТОРЫ PDGFRβ | |
| BRPI0418745A (pt) | anticorpo linhagem de células, composição farmacêutica, e, método de tratamento de cáncer em um paciente | |
| IN2014DN11099A (fr) | ||
| EA201270247A1 (ru) | Способы применения с-мет-модуляторов | |
| NZ598145A (en) | Folate-targeted diagnostics and treatment | |
| SG10201906270VA (en) | Combination therapy comprising a b-raf inhibitor and a second inhibitor | |
| EA201001695A1 (ru) | Применение эпотилона d для лечения заболеваний, связанных с тау-белком | |
| TNSN07191A1 (en) | Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy | |
| SG170752A1 (en) | Benzimidazoles which have activity at m1 receptor and their uses in medicine | |
| MX2007004549A (es) | Tratamiento combinado con bortezomib y un inhibidor de cinasa del receptor del factor de crecimiento epidermico. | |
| MX2009003532A (es) | Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina. | |
| TW200630089A (en) | Treatment methods | |
| MX2014002762A (es) | Uso de proteina c-met para predecir la eficacia de anticuerpos de factor de crecimiento de anti-hepatocitos (hgf) en pacientes con cancer esofagico y gastrico. | |
| PL1781296T3 (pl) | Pochodne chinazolinowe i ich zastosowanie w leczeniu nadpłytkowości | |
| CY1118486T1 (el) | Λαπατινιμπη για τη θεραπεια του καρκινου | |
| EA200870603A1 (ru) | Лечение опухолей у педиатрических пациентов антагонистами рецептора эпидермального фактора роста | |
| TR200902344T1 (tr) | Anti-epidermal büyüme faktörü reseptör antikorları ile terapinin etkisinin geliştirilmesi için terapötik bileşimler. | |
| MX2009006670A (es) | Composicion farmaceutica que usa el aliskiren y el avosentan. | |
| CY1112203T1 (el) | Καινοτομικες θεραπευτικες χρησεις της αδρενεργικης αλφουζοσινης |